# PPLPHARMA share price, delivery % and history — Piramal Pharma Limited

> Delivery percentage for Piramal Pharma Limited (PPLPHARMA) against its own history, with 980 sessions of split-adjusted NSE data from 2022 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/PPLPHARMA

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 206.52 INR (-1.22% on the day), 2026-09-30
- Delivery: 48.21% of volume taken to demat (20-day average 40.84%)
- Volume: 22.41L shares, turnover ₹46.3Cr
- Relative volume: 0.53× of its own 20-day average

## Technicals

- RSI(14): 47.07
- ATR(14): 6.97
- SMA 50: 207.37, SMA 200: 174.16
- 52-week range: 132.3 – 231.93 (-10.96% from the high)

## Performance

- 1 week -2%, 1 month -3.68%, 3 months 22.72%
- 6 months 43.86%, 1 year 3.24%

## Delivery percentage

- Latest: 48.21% (2026-09-30)
- 20-day average: 40.84%
- 1-year average: 38.3%
- Percentile against its own history: 64th
- Range: 5.76% – 100% across 979 sessions with a reading

Over the last 20 sessions PPLPHARMA settled 40.8% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 38.3%, so recent sessions are running 2.5 points higher than usual. The latest session ranks higher than 64% of the 979 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 27,495 crore
- P/E (TTM): — — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): -2.36 INR, split-adjusted to match the price series
- Revenue growth: 17.39% YoY, -17.51% QoQ
- Profit growth: — YoY, — QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 4.85% | — |
| 3y | 7.8% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 2,241.8 | 2,200 | 102.9 | 22.6 | 0.17 | 1.01% |
| 2024-12-31 | 2,204.2 | 2,166.6 | 49.8 | 3.7 | 0.03 | 0.17% |
| 2025-03-31 | 2,754.1 | 2,539.5 | 256.6 | 153.5 | 1.16 | 5.57% |
| 2025-06-30 | 1,933.7 | 2,110.4 | -97.6 | -81.7 | -0.62 | -4.23% |
| 2025-09-30 | 2,043.7 | 2,170.3 | -61 | -99.2 | -0.75 | -4.85% |
| 2025-12-31 | 2,139.9 | 2,246.1 | -104.1 | -136.2 | -1.03 | -6.36% |
| 2026-03-31 | 2,751.8 | 2,592.6 | 29.4 | -8.8 | -0.07 | -0.32% |
| 2026-06-30 | 2,269.9 | 2,386.4 | -27 | -69.4 | -0.52 | -3.06% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 34.8%
- Public: 64.72%
- FII: 12.52%, DII: 14.57%
- Promoter shares pledged: 0%

## Recent filings

- 2026-07-29: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_180189_29072026205615_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697240_20072026060616_WEB.xml
- 2026-04-28: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_153873_28042026214243_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1654598_20042026115851_WEB.xml
- 2026-01-29: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139116_30012026161448_iXBRL_WEB.html
- 2026-01-20: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1605746_20012026045511_WEB.xml
- 2025-11-05: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124669_05112025210037_iXBRL_WEB.html
- 2025-10-17: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1551721_17102025032408_WEB.xml

Dated by the day the company broadcast the filing. 37 events are indexed for this instrument.

## About the instrument

- Listed: 2022-10-19 — latest session 2026-09-30 (980 sessions)
- ISIN: INE0DK501011
- Series: EQ
- Liquidity rank: #320 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/PPLPHARMA.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.